News

BioTech Medics has received an independent clinical testing results for its Shban Hand Sanitizer Solution to prove Shban kills the H1N1 (Swine) Influenza A virus. Reportedly, an ATS

Basilea Pharmaceutica (Basilea) has reported that Toctino (alitretinoin), a new once-daily oral treatment for adults with severe chronic hand eczema (CHE) unresponsive to potent topical corticosteroids, has been

Johnson & Johnson has posted sales of $15.1b for the third quarter of 2009, a decrease of 5.3% compared to the third quarter of 2008. The net earnings

Sanofi Pasteur has reported the interim analysis of data from clinical trials of the US licensed Influenza A (H1N1) 2009 Monovalent Vaccine in infants and children 6 months

The European Commission has granted marketing authorisation to Boehringer Ingelheim for Mirapexin/Sifrol (pramipexole), once daily tablet in all EU/EEA countries. The drug is intended for the treatment of

Pfizer has reported that the US Federal Trade Commission (US FTC) has terminated the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, with respect

Fero Industries has entered into an agreement to acquire Pyro Pharmaceuticals of Irvine, California. Pyro develops therapeutics against multi-drug resistant infectious microorganisms. Pyro’s focus is on diseases in

Ortho Clinical Diagnostics (Ortho) has received FDA approval for Anti-HIV 1+2. Its a diagnostic assay for the detection of antibodies to human immunodeficiency virus (HIV) types 1+2 (Anti-HIV

Galapagos has expanded its global strategic alliance in metabolic diseases with Merck &amp, an affiliate of Merck & Co., to incorporate the development of new therapies for atherosclerosis.